We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.
This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.
|Mohapatra M,Panda M,Kar BR,Raj C, Symmetric Drug-related Intertriginous and Flexural Exanthema due to Itraconazole: An Uncommon Side Effect of a Commonly Used Drug. Indian dermatology online journal. 2017 Nov-Dec; [PubMed]|
|Andersen KE,Hjorth N,Menné T, The baboon syndrome: systemically-induced allergic contact dermatitis. Contact dermatitis. 1984 Feb; [PubMed]|
|Häusermann P,Harr T,Bircher AJ, Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact dermatitis. 2004 Nov-Dec; [PubMed]|
|Nespoulous L,Matei I,Charissoux A,Bédane C,Assikar S, Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature. Contact dermatitis. 2018 Dec; [PubMed]|
|Magnolo N,Metze D,Ständer S, Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2017 Jun; [PubMed]|
|Şikar Aktürk A,Bayramgürler D,Salman S,Yıldız KD,Odyakmaz Demirsoy E, Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by oral metronidazole. Cutaneous and ocular toxicology. 2014 Dec; [PubMed]|
|Daito J,Hanada K,Katoh N,Katoh S,Sakamoto K,Asai J,Takenaka H,Kishimoto S, Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir. Dermatology (Basel, Switzerland). 2009; [PubMed]|
|Arnold AW,Hausermann P,Bach S,Bircher AJ, Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media. Dermatology (Basel, Switzerland). 2007; [PubMed]|
|Tan SC,Tan JW, Symmetrical drug-related intertriginous and flexural exanthema. Current opinion in allergy and clinical immunology. 2011 Aug; [PubMed]|
|Karadag AS,Ozlu E,Akdeniz N,Uzuncakmak TK,Turkoglu Z,Ozkanli S,Zemheri E, Oral mucosal involvement and petechial lesions: a SDRIFE case with unusual findings. Cutaneous and ocular toxicology. 2016; [PubMed]|
|Li DG,Thomas C,Weintraub GS,Mostaghimi A, Symmetrical Drug-related Intertriginous and Flexural Exanthema Induced by Doxycycline. Cureus. 2017 Nov 10; [PubMed]|
|Huynh T,Hughey LC,McKay K,Carney C,Sami N, Systemic drug-related intertriginous and flexural exanthema from radio contrast media: A series of 3 cases. JAAD case reports. 2015 May; [PubMed]|
|Bulur I,Keseroglu HO,Saracoglu ZN,Gönül M, Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with infliximab. Journal of dermatological case reports. 2015 Mar 31; [PubMed]|
|Labadie JG,Florek AG,Croitoru A,Liu W,Krunic AL, First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine, an over-the-counter herbal glycemic control agent. International journal of dermatology. 2018 Sep; [PubMed]|
|Weiss D,Kinaciyan T, Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid. JAAD case reports. 2019 Jan; [PubMed]|
|Yang SY,Lan CC,Hu SC, Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab. International journal of dermatology. 2017 May; [PubMed]|
The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Dermatology-Pediatric. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.
StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Dermatology-Pediatric, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Dermatology-Pediatric, you will already be prepared.
Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Dermatology-Pediatric. When it is time for the Dermatology-Pediatric board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Dermatology-Pediatric.